Israel Englander Inventiva S.A. Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.75 - $15.65 $127,602 - $156,625	-10,008 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.73 - $14.85 $18,970 - $26,254	-1,768 Reduced 15.01%	10,008 $142,000
Q2 2021 Aug 16, 2021	SELL	$13.0 - $15.67 $101,972 - $122,915	-7,844 Reduced 39.98%	11,776 $160,000
Q1 2021 May 17, 2021	SELL	$12.55 - $19.0 $60,691 - $91,884	-4,836 Reduced 19.77%	19,620 $288,000
Q4 2020 Feb 16, 2021	SELL	$11.35 - $14.5 $340,000 - $434,362	-29,956 Reduced 55.05%	24,456 $355,000
Q3 2020 Nov 16, 2020	BUY	$9.87 - $13.42 $537,046 - $730,209	54,412 New	54,412 $642,000

4.85M

Ticker IVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,134,200
Market Cap $110M
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.